טוען...
Construction of homologous cancer cell membrane camouflage in a nano-drug delivery system for the treatment of lymphoma
BACKGROUND: Non-Hodgkin’s lymphoma (NHL) possesses great heterogeneity in cytogenetics, immunophenotype and clinical features, and chemotherapy currently serves as the main treatment modality. Although employing monoclonal antibody targeted drugs has significantly improved its overall efficacy, vari...
שמור ב:
| הוצא לאור ב: | J Nanobiotechnology |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789287/ https://ncbi.nlm.nih.gov/pubmed/33407527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-020-00738-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|